Brilliant Violet 650??? anti-mouse I-A/I-E and 4 more items

The University of Virginia awarded contract A207_PO-0422656-V3 to BioLegend Inc. on June 13, 2026, with a cumulative contract value of $1,464.30. The contract encompasses the procurement of specialized laboratory reagents and immunological research materials. The primary deliverables consist of five distinct line items: 204 units of Brilliant Violet 650 anti-mouse I-A/I-E antibodies, 214 units of Brilliant Violet 711 anti-mouse CD103 antibodies, 212 units of Brilliant Violet 711 anti-mouse interferon-gamma antibodies, 742 units of Streptavidin Nanobead magnetic particles, and 90 units of PE/Cyanine7 anti-IRF4 antibodies, totaling 1,462 units across all line items.

These materials are classified as research-grade flow cytometry reagents and immunological assay components commonly utilized in laboratory research applications. Each line item reflects unit pricing of $1.00 per unit, with delivery specified to the University of Virginia as the buyer. The contract was executed in Virginia and represents a modest procurement typical of research institution consumable material acquisitions. No additional information regarding contract performance period or specific cost categories beyond cumulative value is provided in the available documentation.